Mohamed-Reda Benmebarek

Author

Ludwig-Maximilians-Universität München ORCID

Also Known As

M Benmebarek, M. Benmebarek, M.-R. Benmebarek, Mohamed-Reda Benmebarek, Reda Benmebarek

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

Ludwig-Maximilians-Universität München National Cancer Institute Center for Cancer Research Helmholtz Zentrum München National Institutes of Health

About

Mohamed-Reda Benmebarek is an author at Ludwig-Maximilians-Universität München specializing in medicine, immunology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	479
2	Immunology	4	4	479
3	Cell Biology	3	3	340
4	Pathology	1	1	139
5	Autoimmunity	1	1	77

Mohamed-Reda Benmebarek

Publications

840

Citations

H-Index

Page 1

	Year	Citations
T cells armed with C-X-C chemokine receptor type 6 enhance adoptive cell therapy for pancreatic tumours Stefanie Lesch, Viktoria Blumenberg, Stefan Stoiber, Nature Biomedical Engineering Cancer ImmunosurveillancePancreatic CancerT CellsMedicinePancreatic Tumours	2021	161
Tumor-associated macrophages trigger MAIT cell dysfunction at the HCC invasive margin Benjamin Ruf, Matthias Bruhns, Sepideh Babaei, Cell InflammationTumor-associated MacrophagesCancer ImmunosurveillanceMait Cell DysfunctionImmunology	2023	139
Single-cell transcriptomic atlas-guided development of CAR-T cells for the treatment of acute myeloid leukemia Adrian Gottschlich, Moritz Thomas, Ruth Grünmeier, Nature Biotechnology Hematological MalignancyCar-t CellsMixed-phenotype Acute LeukemiaAcute Myeloid LeukemiaMalignant Blood Disorder	2023	102
Combined tumor-directed recruitment and protection from immune suppression enable CAR T cell efficacy in solid tumors Bruno L. Cadilha, Mohamed-Reda Benmebarek, Klara Dorman, Science Advances	2021	95
Paralysis of the cytotoxic granule machinery is a new cancer immune evasion mechanism mediated by chitinase 3-like-1 Abbass Darwich, Alessandra Silvestri, Mohamed-Reda Benmebarek, Journal for ImmunoTherapy of Cancer ImmunologyImmunoeditingCell DeathImmunologic MechanismImmunotherapy	2021	77
Bispecific Antibodies Enable Synthetic Agonistic Receptor-Transduced T Cells for Tumor Immunotherapy Clara H. Karches, Mohamed-Reda Benmebarek, Moritz L. Schmidbauer, Clinical Cancer Research	2019	43
Impact of the selective A2AR and A2BR dual antagonist AB928/etrumadenant on CAR T cell function Matthias Seifert, Mohamed-Reda Benmebarek, Daria Briukhovetska, British Journal of Cancer	2022	37
A modular and controllable T cell therapy platform for acute myeloid leukemia Mohamed-Reda Benmebarek, Bruno L. Cadilha, Monika Herrmann, Leukemia	2021	32
Chimeric antigen receptor T cells engineered to recognize the P329G-mutated Fc part of effector-silenced tumor antigen-targeting human IgG1 antibodies enable modular targeting of solid tumors Sophia Stock, Mohamed-Reda Benmebarek, Anna-Kristina Kluever, Journal for ImmunoTherapy of Cancer	2022	27
SPP1 + macrophages cause exhaustion of tumor-specific T cells in liver metastases Rajiv Trehan, Patrick Huang, Xiao Bin Zhu, Nature Communications	2025	25

Page 1